Gaetan H. Bourgoin v. Twin Rivers Paper Company, LLC
This text of 2018 ME 77 (Gaetan H. Bourgoin v. Twin Rivers Paper Company, LLC) is published on Counsel Stack Legal Research, covering Supreme Judicial Court of Maine primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinions
Dissent: ALEXANDER, J.
HJELM, J.
[¶ 1] After sustaining a work-related injury, Gaetan H. Bourgoin was issued a certification to use medical marijuana as a result of chronic back pain. He successfully petitioned the Workers' Compensation Board for an order requiring his former employer, Twin Rivers Paper Company, LLC, to pay for the medical marijuana. On this appeal from the decision of the Appellate Division affirming that award, we are called upon for the first time to consider the relationship between the federal Controlled Substances Act (CSA) and the Maine Medical Use of Marijuana Act (MMUMA). We conclude that in the narrow circumstances of this case-where an employer is subject to an order that would require it to subsidize an employee's acquisition of medical marijuana-there is a positive conflict between federal and state law, and as a result, the CSA preempts the MMUMA as applied here.
See
I. BACKGROUND
[¶ 2] Twin Rivers Paper Company, LLC, and Sedgwick Claims Management Services (collectively, Twin Rivers) appeal from a decision of the Workers' Compensation Board Appellate Division affirming a hearing officer's (
Pelletier, HO
)
[¶ 3] We draw the following facts, which are supported by the record, from the hearing officer's decree.
See
Bailey v. City of Lewiston
,
[¶ 4] Bourgoin worked as a paper machine laborer for Fraser Papers, which was subsequently acquired by Twin Rivers, at a paper mill in Madawaska from 1980 until 1989, when he sustained a work-related back injury. By agreement of the employer, Bourgoin was placed on total disability as a result of the injury. On three occasions, Twin Rivers filed a petition seeking a reduction in Bourgoin's incapacity, but each petition was denied, and he remains on total disability.
[¶ 5] As a result of his workplace injury, Bourgoin suffers from severe chronic pain syndrome. Bourgoin consulted with a number of pain management specialists and attempted a variety of treatments, including opioid medications, for his pain. Due to adverse side effects of his continued use of opioids, and on the recommendation of his primary care physician, Bourgoin stopped using narcotic medications. In January of 2012, Bourgoin obtained a medical marijuana certification and since then has used medical marijuana to manage his chronic pain. See 22 M.R.S. §§ 2421 to 2430-B (2017).
[¶ 6] In February of 2012, Bourgoin filed a "petition for payment of medical and related services" with the Workers' Compensation Board seeking payment from Twin Rivers for the cost of the medical marijuana. Twin Rivers opposed the petition on the ground, among others, that an order requiring it to pay for Bourgoin's medical marijuana is barred by the CSA even if his use of medical marijuana were permitted by the MMUMA. Following a hearing, the hearing officer granted Bourgoin's petition in a written decision issued in March of 2015. Twin Rivers appealed to the Appellate Division, which affirmed the hearing officer's decision in August of 2016. We then granted Twin Rivers' petition for appellate review.
See
39-A M.R.S. § 322 (2017) ; M.R. App. P. 23 (Tower 2016).
II. DISCUSSION
[¶ 7] Twin Rivers argues that the Controlled Substances Act,
A. Preemption Principles
[¶ 8] The preemption analysis must begin with the Supremacy Clause of the United States Constitution, which "unambiguously provides that if there is any conflict between federal and state law, federal
law shall prevail."
Gonzales v. Raich
,
Free access — add to your briefcase to read the full text and ask questions with AI
Dissent: ALEXANDER, J.
HJELM, J.
[¶ 1] After sustaining a work-related injury, Gaetan H. Bourgoin was issued a certification to use medical marijuana as a result of chronic back pain. He successfully petitioned the Workers' Compensation Board for an order requiring his former employer, Twin Rivers Paper Company, LLC, to pay for the medical marijuana. On this appeal from the decision of the Appellate Division affirming that award, we are called upon for the first time to consider the relationship between the federal Controlled Substances Act (CSA) and the Maine Medical Use of Marijuana Act (MMUMA). We conclude that in the narrow circumstances of this case-where an employer is subject to an order that would require it to subsidize an employee's acquisition of medical marijuana-there is a positive conflict between federal and state law, and as a result, the CSA preempts the MMUMA as applied here.
See
I. BACKGROUND
[¶ 2] Twin Rivers Paper Company, LLC, and Sedgwick Claims Management Services (collectively, Twin Rivers) appeal from a decision of the Workers' Compensation Board Appellate Division affirming a hearing officer's (
Pelletier, HO
)
[¶ 3] We draw the following facts, which are supported by the record, from the hearing officer's decree.
See
Bailey v. City of Lewiston
,
[¶ 4] Bourgoin worked as a paper machine laborer for Fraser Papers, which was subsequently acquired by Twin Rivers, at a paper mill in Madawaska from 1980 until 1989, when he sustained a work-related back injury. By agreement of the employer, Bourgoin was placed on total disability as a result of the injury. On three occasions, Twin Rivers filed a petition seeking a reduction in Bourgoin's incapacity, but each petition was denied, and he remains on total disability.
[¶ 5] As a result of his workplace injury, Bourgoin suffers from severe chronic pain syndrome. Bourgoin consulted with a number of pain management specialists and attempted a variety of treatments, including opioid medications, for his pain. Due to adverse side effects of his continued use of opioids, and on the recommendation of his primary care physician, Bourgoin stopped using narcotic medications. In January of 2012, Bourgoin obtained a medical marijuana certification and since then has used medical marijuana to manage his chronic pain. See 22 M.R.S. §§ 2421 to 2430-B (2017).
[¶ 6] In February of 2012, Bourgoin filed a "petition for payment of medical and related services" with the Workers' Compensation Board seeking payment from Twin Rivers for the cost of the medical marijuana. Twin Rivers opposed the petition on the ground, among others, that an order requiring it to pay for Bourgoin's medical marijuana is barred by the CSA even if his use of medical marijuana were permitted by the MMUMA. Following a hearing, the hearing officer granted Bourgoin's petition in a written decision issued in March of 2015. Twin Rivers appealed to the Appellate Division, which affirmed the hearing officer's decision in August of 2016. We then granted Twin Rivers' petition for appellate review.
See
39-A M.R.S. § 322 (2017) ; M.R. App. P. 23 (Tower 2016).
II. DISCUSSION
[¶ 7] Twin Rivers argues that the Controlled Substances Act,
A. Preemption Principles
[¶ 8] The preemption analysis must begin with the Supremacy Clause of the United States Constitution, which "unambiguously provides that if there is any conflict between federal and state law, federal
law shall prevail."
Gonzales v. Raich
,
[¶ 9] Federal law can preempt state law in three ways: first, by express preemption, where Congress expressly states that federal law preempts the state law; second, by field preemption, where Congress explicitly or implicitly leaves "no room" for state law, or where federal law is "so dominant" that it "will be assumed to preclude enforcement" of the state law; and third, by conflict preemption, where the state law "actually conflicts with federal law."
Hillsborough Cty. v. Automated Med. Labs., Inc.
,
[¶ 10] Conflict preemption arises in two circumstances. The first is where "compliance with both federal and state [law] is a physical impossibility,"
see
Hillsborough Cty.
,
[¶ 11] Here, Congress expressly regulated the consequence of any conflict that arises between the CSA and state law by including the following provision in the CSA:
No provision of this title shall be construed as indicating an intent on the part of the Congress to occupy the field in which that provision operates, including criminal penalties, to the exclusion of any State law on the same subject matter which would otherwise be within the authority of the State, unless there is a positive conflict between that provision of this title and that State law so that the two cannot consistently stand together.
B. The Controlled Substances Act
[¶ 12] Nearly half a century ago, the United States Congress enacted the Comprehensive Drug Abuse Prevention and Control Act of 1970, Pub. L. No. 91-513,
[¶ 13] The CSA classifies substances subject to that legislation into five schedules that are differentiated based on three factors: their respective potential for abuse, the existence-or absence-of their currently accepted medical use, and risks they pose even when used under medical supervision.
See
21 U.S.C.S § 812(a), (b). Marijuana is classified as a Schedule I drug,
see
[¶ 14] Although the CSA requires periodic updates of the schedules of controlled substances by the United States Attorney General,
see
[¶ 15] Because marijuana is a Schedule I substance, the CSA makes it a crime to knowingly or intentionally "manufacture, distribute, or dispense, or possess with intent to manufacture, distribute, or dispense" marijuana,
[¶ 16] The mens rea required for aiding and abetting is an "intent [that] must go to the specific and entire crime charged," such as "when a person actively participates in a criminal venture with full knowledge of the circumstances constituting the charged offense."
[¶ 17] It also bears noting that aside from the exposure to a federal conviction itself, the penalties for violation of the CSA can be significant. Pursuant to the least severe penalty range for a violation of section 844 -and, consequently, for aiding or abetting another person's violation of section 844 -the sentence, at minimum, is a mandatory fine of $1,000, and it may also include as much as one year of incarceration, with an even greater sentence if certain aggravating factors are present, such as a prior conviction for any drug offense, including offenses established by the CSA.
See
C. The CSA and Maine's Medical Marijuana Law
[¶ 18] This description of the scope and effect of federal regulation of marijuana brings us to the point where the CSA and Maine law intersect. As relevant to this case, the Maine Medical Use of Marijuana Act, 22 M.R.S. §§ 2421 to 2430-B, allows a "qualifying patient"
[¶ 19] These conflicting federal and state laws, and their embodiment of competing policies and underlying conclusions about the efficacy of marijuana as a legitimate therapeutic substance, frame the narrow issue that is central to this case: given this network of statutes, can Twin Rivers be required to pay for Bourgoin's acquisition and use of marijuana-conduct that is proscribed by federal law but allowed by the State because a MMUMA certification had been issued to him?
[¶ 20] Compliance with both is an impossibility. Were Twin Rivers to comply with the hearing officer's order and knowingly reimburse Bourgoin for the cost of the medical marijuana as permitted by the MMUMA, Twin Rivers would necessarily engage in conduct made criminal by the CSA because Twin Rivers would be aiding and abetting Bourgoin-in his purchase, possession, and use of marijuana-by acting with knowledge that it was subsidizing Bourgoin's purchase of marijuana.
See
[¶ 21] Several courts have held that a consumer's state-law-compliant
choice
to use medical marijuana does not trigger the limited preemption provision of section 903.
See, e.g.
,
Reed-Kaliher v. Hoggatt
,
[¶ 22] The preemptive effect of the CSA on state marijuana laws has been addressed in several cases involving circumstances similar to the one presented here, where a party-such as Twin Rivers-was confronted with a mandate to engage in conduct that would be violative of the CSA. Two courts, for example, have held that a state law authorizing medical marijuana use does not require an employer to treat an employee's medical use of marijuana as a reasonable workplace accommodation.
See
Garcia
,
Emerald Steel Fabricators, Inc. v. Bureau of Labor & Indus.
,
[¶ 23] Similarly, the Oregon Supreme Court has held that Oregon's medical marijuana law did not
require
an employer to accommodate an employee's use of medical marijuana pursuant to the principle of obstacle preemption, a form of conflict preemption,
see
supra
¶10, and therefore that "[t]o the extent that [the state medical marijuana law] affirmatively authorizes the use of medical marijuana, federal law preempts that subsection, leaving it without effect."
Emerald Steel Fabricators, Inc.
,
[¶ 24] As these cases demonstrate, a person's right to use medical marijuana cannot be converted into a sword that would require another party, such as Twin Rivers, to engage in conduct that would violate the CSA.
[¶ 25] In a third case of relevance, although presenting a very different factual situation, the Supreme Court of Colorado considered whether the Colorado medical marijuana law-which is now part of that state's Constitution,
see
Colo. Const. art. XVIII, § 14-may be enforced in a way that would violate the CSA.
Crouse
,
[¶ 26] In affirming the hearing officer's decision, the Appellate Division
[¶ 27] Even more significantly, the Ogden Memo itself made clear that it was directed only to the question of
enforcement
of laws but did nothing to challenge their
existence
. David W. Ogden, Deputy Att'y Gen., U.S. Dep't of Justice, Memorandum for Selected United States Attorneys: Investigations and Prosecutions in States Authorizing the Medical Use of Marijuana 1;
see
United States v. Hicks
,
[¶ 28] Most importantly, however, the magnitude of the
risk
of criminal prosecution is immaterial in this case. Prosecuted or not, the fact remains that Twin Rivers would be forced to commit a federal crime if it complied with the directive of the
Workers' Compensation Board.
III. CONCLUSION
[¶ 29] Through its enactment of the MMUMA, the Maine Legislature has exempted qualifying patients and other specified individuals from state prosecution that otherwise could arise from the medical use of marijuana. The Legislature, however, does not have the power to change or restrict the application of federal law that positively conflicts with state law.
See
U.S. Const. art. VI, cl. 2. So long as marijuana remains a Schedule I substance under the CSA,
see
[¶ 30] Because the CSA preempts the MMUMA when the MMUMA is used as the basis for requiring an employer to reimburse an employee for the cost of medical marijuana, the order based on the MMUMA must yield. We therefore vacate the decision of the Appellate Division.
The entry is:
Judgment vacated. Remanded to the Workers' Compensation Appellate Division with instructions to vacate the decision of the hearing officer and remand for denial of the petition for payment of medical expenses and services.
JABAR, J., with whom ALEXANDER, J., joins, dissenting.
[¶ 31] I respectfully dissent because I do not believe that the federal Controlled Substances Act (CSA) preempts the Maine Medical Use of Marijuana Act (MMUMA) in this case.
A. Preemption Analysis
[¶ 32] The United States Supreme Court has recognized that in "all pre-emption cases, and particularly in those in which Congress has legislated ... in a field
which the States have traditionally occupied, ... we start with the assumption that the historic police powers of the States were not to be superseded by the Federal Act unless that was the clear and manifest purpose of Congress."
Wyeth v. Levine
,
In cases where federal law is said to bar state action in fields of traditional state regulation, such as workers' compensation legislation , there is an assumption that the historic police powers of the States were not to be superseded by the Federal Act unless that was the clear and manifest intent [of Congress].
Ciampi v. Hannaford Bros. Co.
,
[¶ 33] In order to determine whether the CSA preempts the MMUMA here, we must determine whether it is the "clear" or "manifest" purpose of Congress to preempt a state workers' compensation board from ordering an employer to reimburse an employee for valid medical expenses related to properly certified medical marijuana. As the Court states, the CSA contains the following provision regarding preemption:
No provision of this title shall be construed as indicating an intent on the part of the Congress to occupy the field in which that provision operates, including criminal penalties, to the exclusion of any State law on the same subject matter which would otherwise be within the authority of the State, unless there is a positive conflict between that provision of this title and that State law so that the two cannot consistently stand together.
[¶ 34] A positive conflict arises "when compliance with both state and federal requirements is
impossible
."
Robards v. Cotton Mill Assocs.
,
The phrase positive conflict ... so that the two cannot consistently stand together in section 903 has been interpreted as narrowly restricting the preemptive reach of the CSA to cases of an actual conflict with federal law such that compliance with both federal and state regulations is a physical impossibility. Justice Scalia has written that the plain language of section 903 states a congressional intent that the CSA preempt only state laws that require someone to engage in an action specifically forbidden by the CSA. As a California appellate court succinctly put it, mere speculation about a hypothetical conflict is not the stuff of which preemption is made.
It is not physically impossible to comply with both the CSA and state marijuana laws; nothing in the more liberal state laws requires anyone to act contrary to the CSA. Only if a state law required a citizen to possess , manufacture , or distribute marijuana in violation of federal law would it be impossible for a citizen to comply with both state and federal law. Similarly, if a state were to make state officers the manufacturers or distributors of marijuana, it might well be impossible for those officials to comply with both state and federal law. No state marijuana law, however, has attempted to require state or local officials to violate the CSA in this manner.
Erwin Chemerinsky et al.,
Cooperative Federalism and Marijuana Regulation
,
[¶ 35] Turning to the supposedly conflicting laws, the MMUMA allows a medical provider to "provide a written certification for the medical use of marijuana" if a "qualifying patient is likely to receive therapeutic benefit" from its use "to treat or alleviate the patient's debilitating medical condition." 22 M.R.S. § 2423-B (2017). Pursuant to the CSA, on the other hand, it is "unlawful for any person knowingly or intentionally ... to manufacture, distribute, or dispense, or possess with intent to manufacture, distribute, or dispense" marijuana.
[¶ 36] Here, there is no positive conflict between the CSA and the MMUMA because there is no state law that requires the employer-or any person or entity-to possess, manufacture, or distribute marijuana. In other words, compliance with both the federal law and the Workers' Compensation Board (WCB) order is possible: reimbursement does not require the employer to
physically
manufacture, distribute, dispense, or possess marijuana, and, as a result, no physical impossibility exists between the federal law and the WCB order in this case. Adopting Chemerinsky's analysis of section 903 of the CSA, because there is no physical impossibility here, and because Congress has not expressed a clear and manifest preemptive intent regarding state workers' compensation boards and reimbursement for state-law compliant medical marijuana use,
see
Ciampi
,
[¶ 37] The employer and the Court point to the Colorado case of
People v. Crouse
to support the argument that reimbursement creates a positive conflict.
[¶ 38] This case is unlike People v. Crouse . There is a difference in both nature and degree between following a WCB
order to reimburse a worker for medical treatment authorized by a physician and approved by the WCB and a state law that requires police officers to physically distribute marijuana. The key distinction is that the police officers' actions in
Crouse
fit within an actual, proscribed activity specifically
defined
by the CSA.
See
Crouse
,
B. Aiding and Abetting
[¶ 39] The Court's primary legal theory-that because the employer would be aiding and abetting Bourgoin's possession, the CSA preempts the MMUMA here-is unpersuasive because the government would not be able to prove that the employer would be acting with the specific intent necessary to establish the requisite mens rea element of the offense of aiding and abetting.
See
[¶ 40] A person is punishable as a principal under federal law if that person "aids, abets, counsels, commands, induces or procures [a crime's] commission" or "willfully causes an act to be done which if directly performed by [that person] or another would be an offense against the United States."
[¶ 41] Since
Nye & Nissen
, federal courts have continued to hold that the accomplice must
wish
or
desire
to bring about the success of the principal in committing the underlying substantive offense in order to be punishable as a principal.
See
United States v. Zafiro
,
[¶ 42] In other words, the crime of aiding and abetting is a specific intent crime.
See
United States v. Nacotee
,
To be proved guilty of aiding and abetting, [it] must be established[ ] that the defendant desired the illegal activity to succeed. The purpose of this requirement is a little mysterious but we think it is to identify, and confine punishment to, those forms of assistance the prevention of which makes it more difficult to carry on the illegal activity assisted.
[¶ 43] In distancing its own analysis and view of liability for aiding and abetting from that set forth here, the Court distinguishes between the criminal liability element contained in, on the one hand,
[¶ 44] In this context, the common law establishes the requisite mens rea element for all of section two.
See
Nye & Nissen
,
[¶ 45] Here, the employer's compliance with the WCB's order to reimburse Bourgoin's state-law-compliant medical expenses is insufficient to give rise to the specific intent element of aiding and abetting, regardless of with which prong under section two the United States may or may not charge the employer. The Court does not analyze how the government would be able to meet its burden to prove beyond a reasonable doubt that the employer itself actually
desired
or
wished
that Bourgoin be successful in committing the underlying federal offense; I do not agree that mere knowledge is sufficient. According to the Court, however, the employer "would be aiding and abetting Bourgoin-in his purchase, possession, and use of marijuana-
by acting with knowledge
that it was subsidizing Bourgoin's purchase of marijuana." Court's Opinion ¶ 20 (emphasis added). To support this proposition, the Court cites to, among other sources of law,
Rosemond v. United States
,
[¶ 46] In contrast, the employer in this case is even further removed from Bourgoin than the gun store owner is from the "criminal" in the Rosemond hypothetical; completely disinterested in Bourgoin's use or possession of marijuana-and indeed only reimbursing him for his medical expenses as ordered by the WCB-the employer is not an active participant in the substantive "offense" of Bourgoin's possession. Contrary to the Court's conclusion, I do not agree that mere knowledge constitutes active participation in the commission of a crime, the effective accomplishment of which the accomplice himself or herself must wish or desire to bring about in order to establish the requisite specific intent that the offense of aiding and abetting demands.
[¶ 47] In fact, the existence of this litigation vitiates the specific intent element that the government would have to prove if it even decided to prosecute the employer. Regardless, whether the government would be able to prove the requisite mens rea beyond a reasonable doubt is speculative, and because speculative conflicts and hypotheticals do not give rise to preemption,
see, e.g.
,
Exxon Corp.
,
order, especially in light of the strong presumption against preemption in this state-controlled area of workers' compensation-a domain that has traditionally been regulated under the police powers of the states.
See
Ciampi
,
[¶ 48] The Court also discusses the employer's offense of aiding and abetting in a vacuum, devoid of any mention of the substantive offense, which would be Bourgoin's state-law-compliant use and possession of medical marijuana. The Court points to no federal prosecution of possession of medical marijuana, let alone a federal prosecution of aiding and abetting a singular person's simple possession of medical marijuana.
[¶ 49] Because I would hold that there is no positive conflict between the CSA and the MMUMA in this case, I address the remainder of the employer's arguments on appeal.
C. Private Health Insurers
[¶ 50] The employer argues that the plain language contained in section 2426(2)(A) of the MMUMA demonstrates a legislative intent that no third party should be required to reimburse a person for their use of medical marijuana.
See
22 M.R.S. § 2426(2)(A) (2017). We review issues of statutory interpretation de novo.
See
Estate of Sullwold v. Salvation Army
,
[¶ 51] "The cardinal rule of statutory construction is to ascertain and effectuate the intent of the legislature."
State v. Hudson
,
[¶ 52] The MMUMA states that it "may not be construed to require ... [a] government medical assistance program or private health insurer to reimburse a person for costs associated with the medical use of marijuana." 22 M.R.S. § 2426(2)(A). The MMUMA does not define "private health insurer."
See
22 M.R.S. § 2422 (2017). However, the Workers' Compensation Act (WCA) defines "employer," "[i]f the employer is insured," to include "the insurer, self-insurer or group self-insurer." 39-A M.R.S. § 102(12) (2017). Under the WCA, "insurance company" is separately defined as "any casualty insurance company or association authorized to do business in this State that may issue policies" and does not include employers.
[¶ 53] We must first look to the plain meaning of "private health insurer" under the MMUMA and construe that language to avoid an absurd, inconsistent, or illogical result.
See
Hanson v. S.D. Warren Co.
,
D. Reasonable and Proper Treatment
[¶ 54] The employer argues that medical marijuana is not a reasonable and proper form of treatment under the WCA because it is illegal under the CSA; it has not been shown to have an accepted level of safety; there is no control over the quality of the substance; and there is no control over its billing. We review issues of statutory interpretation de novo.
See
Estate of Sullwold
,
[¶ 55] "When construing provisions of the Workers' Compensation Act, our purpose is to give effect to the Legislature's intent."
Graves v. Brockway-Smith Co.
,
[¶ 56] The WCA does not define what "reasonable and proper" means.
See generally
39-A M.R.S. § 102 (2017). However, we have held that the "reasonable and proper" language contained within the WCA is "unambiguous on its face" and that "the Legislature sought to provide payment by the employer for all reasonable and proper medical ... services ... required by an employee sustaining a personal injury arising out of and in the course of his employment."
Cote v. Georgia-Pacific Corp.
,
[¶ 57] Turning to the particular facts of Bourgoin's own case, Bourgoin suffers from severe chronic pain syndrome, which includes symptoms of pain and muscle spasms in his back, legs, arms, and chest. Bourgoin has attempted many treatments since he was placed on total disability in 1989, including nerve blocks, aquatherapy, and pain management through opioid medication. Eventually, the continued use of opioid medication resulted in severe negative side effects, including narcotic dependence, with dependency dating as far back as the 1990s, and suicidal ideation. The hearing officer found that strong narcotic medications "have already been tried and they have failed Mr. Bourgoin miserably." As a result, and after consultation with his psychiatrist, his primary doctor recommended ceasing narcotic medications, and in January of 2012, Bourgoin obtained a medical marijuana certification from a physician. Bourgoin has used medical marijuana since his certification to successfully treat his chronic pain, and the hearing officer found that Bourgoin "has experienced significant benefit from medical marijuana, and that opioids have already been shown to be a failure."
[¶ 58] With no reference to the "particular facts" of Bourgoin's case, the employer here argues that medical marijuana is per se unreasonable and improper for Bourgoin because possession of marijuana is unlawful under the CSA. I would decline to adopt this argument and would conclude that medical marijuana was reasonable and proper here based on the particular facts of Bourgoin's own case, as established by the record before us. Specifically, the severity and chronic nature of his pain, his many and varied attempts to try different treatments, none of which were effective, and the ultimate effectiveness of medical marijuana for his particular situation, show that the medical use of marijuana was reasonable and proper in this case.
E. Rejection of IME's Findings
[¶ 59] The employer argues that there was not clear and convincing evidence to contradict the independent medical examiner's (IME) findings, and that the hearing officer's analysis was flawed because it failed to consider whether medical marijuana can ever be reasonable "given its illegality under the CSA."
[¶ 60] A hearing officer must adopt the medical findings of the IME "unless there is clear and convincing evidence to the contrary in the record that does not support the medical findings." 39-A M.R.S. § 312(7) (2017). Although a hearing officer's decision "on all questions of fact is final," a hearing officer's conclusion that an employee satisfied his or her burden to prove by clear and convincing evidence that the independent medical examiner's findings should be rejected is a conclusion of law that is subject to appellate review. 39-A M.R.S. § 318 (2017).
[¶ 61] In this case, the hearing officer found it to be highly probable that the record did not support the IME's findings. Specifically, the hearing officer was persuaded by the testimony of Dr. Sulak regarding the benefits of marijuana for the treatment of long-term, chronic pain, and Bourgoin's own testimony regarding the effects of marijuana on his level of pain. The hearing officer found this evidence to be more persuasive than the IME's findings. The IME concluded that, because medical marijuana had no currently accepted medical use under federal law, it was not a reasonable and proper treatment for any patient, regardless of its efficacy in a given circumstance.
[¶ 62] Because the record contains (1) numerous examples of the ways in which medical marijuana has reduced Bourgoin's chronic pain since beginning the regimen of medical marijuana use; and (2) evidence of traditional opioid medication's failure to reduce his chronic pain, I would hold that the hearing officer could have been reasonably persuaded by the contrary medical evidence, and, as a result, that he did not err when he concluded that it was highly probable that the record did not support the IME's medical findings.
[¶ 63] Accordingly, I would affirm the decision of the Appellate Division.
Related
Cite This Page — Counsel Stack
2018 ME 77, 187 A.3d 10, Counsel Stack Legal Research, https://law.counselstack.com/opinion/gaetan-h-bourgoin-v-twin-rivers-paper-company-llc-me-2018.